Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Gross Profit (2016 - 2025)

Biomerica's Gross Profit history spans 16 years, with the latest figure at $53000.0 for Q4 2025.

  • For Q4 2025, Gross Profit fell 87.87% year-over-year to $53000.0; the TTM value through Nov 2025 reached $249000.0, down 58.29%, while the annual FY2025 figure was $498000.0, 18.49% down from the prior year.
  • Gross Profit for Q4 2025 was $53000.0 at Biomerica, down from $424000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $1.7 million in Q1 2022 and bottomed at -$247000.0 in Q2 2025.
  • The 5-year median for Gross Profit is $204500.0 (2023), against an average of $265342.4.
  • The largest annual shift saw Gross Profit surged 2378.63% in 2022 before it crashed 1335.0% in 2025.
  • A 5-year view of Gross Profit shows it stood at $771759.0 in 2021, then crashed by 54.41% to $351875.0 in 2022, then fell by 7.64% to $325000.0 in 2023, then surged by 34.46% to $437000.0 in 2024, then crashed by 87.87% to $53000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Gross Profit are $53000.0 (Q4 2025), $424000.0 (Q3 2025), and -$247000.0 (Q2 2025).